Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer (clinicaltrials.gov) - May 16, 2026 - P1 | N=14 | Recruiting | Sponsor: Roswell Park Cancer Institute | Trial completion date: Dec 2027 ➔ Dec 2029 | Trial primary completion date: Dec 2026 ➔ Dec 2029
Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • CNS Disorders • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|